Provided by Tiger Trade Technology Pte. Ltd.

West Pharmaceutical

339.40
+2.460.73%
Volume:293.95K
Turnover:98.62M
Market Cap:23.98B
PE:43.46
High:342.62
Open:332.50
Low:331.99
Close:336.94
52wk High:386.00
52wk Low:223.83
Shares:70.65M
Float Shares:69.93M
Volume Ratio:1.05
T/O Rate:0.42%
Dividend:0.87
Dividend Rate:0.26%
EPS(TTM):7.81
EPS(LYR):6.79
ROE:19.09%
ROA:11.38%
PB:8.02
PE(LYR):49.99

Loading ...

Jul 25, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 25, 2024

Major Issues Report

Form 8-K - Current report
Jul 08, 2024

Major Issues Report

Form 8-K - Current report
Jun 26, 2024

Employee Stock Ownership

Form 11-K - Annual report of employee stock purchase, savings and similar plans
Jun 26, 2024

Employee Stock Ownership

Form 11-K - Annual report of employee stock purchase, savings and similar plans
May 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 26, 2024

Major Issues Report

Form 8-K - Current report
Apr 25, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 25, 2024

Major Issues Report

Form 8-K - Current report
Feb 28, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 20, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2024

Major Issues Report

Form 8-K - Current report
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 01, 2023

Major Issues Report

Form 8-K - Current report
Oct 27, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 26, 2023

Major Issues Report

Form 8-K - Current report
Sep 22, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 28, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]